当前位置: 首页 > 期刊 > 《上海医药》 > 2024年第18期
编号:2266717
近5年中医药治疗原发性骨质疏松症研究进展
http://www.100md.com 2024年12月31日 上海医药 2024年第18期
     摘 要 随着我国“老龄化”程度的不断加剧,骨质疏松症患者的罹患率也在不断攀升,已成为现阶段社区常见的骨性疾病,中医治疗该病方法繁多,疗效也很明显。本文检索近5年关于中医药治疗骨质疏松症的相关研究报道,分别从病因病机、临床分型、内服外治等方面进行综述。

    关键词 原发性骨质疏松症;中医药;治疗

    中图分类号:R259 文献标志码:A 文章编号:1006-1533(2024)18-0016-03

    引用本文 王译, 吴耀持, 周雯睿, 等. 近5年中医药治疗原发性骨质疏松症研究进展[J]. 上海医药, 2024, 45(18): 16-18; 44.

    基金项目:上海市宝山区科学技术委员会课题(2023-E-60)

    Research progress of traditional Chinese medicine in the treatment of primary osteoporosis in recent 5 years

    WANG Yi1, WU Yaochi2, ZHOU Wenrui1, GU Huanghuan1, TANG Shi3

    (1. Traditional Chinese Medicine Department of Youyi Community Health Service Center of Baoshan District, Shanghai 201999, China; 2. Acupuncture, Massage and Orthopedics Department of the Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University, Shanghai 200233, China; 3. Traditional Chinese Medicine Department of Yinghang Community Health Service Center of Yangpu District, Shanghai 200438, China)

    ABSTRACT Continuously intensifying of aging population in our country, the incidence rate of osteoporosis is also increasing, and has become a community common bone disease. Traditional Chinese medicine has a variety of treatment methods and the therapeutic effect is also very obvious. The article retrieves relevant research reports on the treatment of osteoporosis with traditional Chinese medicine in the past five years ......

您现在查看是摘要页,全文长 11157 字符